WallStreetZen

AnalystsSel Hardy
Sel Hardy's Stock Forecasts

Analyst Ranking
Top 3%
#77 out of 3474 analysts
Average Return
+133.81%
Win Rate
100%12 out of 12
Risk vs Reward
Poor
Good

Sel Hardy's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Owens & Minor IncOMI
+496.69%$7.86$46.90
2020-06-09 -
2021-06-10
Buy
Owens & Minor IncOMI
+390.14%$7.00$34.31
2020-05-06 -
2021-05-07
Buy
Owens & Minor IncOMI
+349.46%$8.39$37.71
2020-03-29 -
2021-03-30
Buy
Iqvia Holdings IncIQV
+92.04%$96.91$186.11
2020-03-23 -
2021-03-24
Buy
Charles River Laboratories International IncCRL
+66.89%$173.32$289.25
2020-02-10 -
2021-02-11
Strong Buy

Sel Hardy's Stock Coverage

Name / Ticker# of RatingsRatingPrice TargetUpside/DownsideActionDate
American Eagle Outfitters IncAEO
1Hold$28.00+16.42%Downgrades
2 months ago
Owens & Minor IncOMI
3Buy$9.50N/AMaintains
a year ago
Mckesson CorpMCK
1Buy$171.00N/AMaintains
a year ago
Cardinal Health IncCAH
2Hold$58.00N/AMaintains
a year ago
Mettler Toledo International IncMTD
1Hold$741.00N/AMaintains
a year ago
Bausch Health Companies IncBHC
1Hold$18.00N/AMaintains
a year ago
Bristol Myers Squibb CoBMY
1Buy$70.00N/AMaintains
a year ago
Perkinelmer IncPKI
1Hold$94.00N/AMaintains
a year ago
Henry Schein IncHSIC
1Hold$60.00N/AMaintains
a year ago
Molina Healthcare IncMOH
2Buy$191.00N/AUpgrades
a year ago
Syneos Health IncSYNH
1Buy$61.00N/AMaintains
a year ago
Anthem IncANTM
1Buy$306.00N/AUpgrades
a year ago
ELI LILLY & CoLLY
1Hold$167.00N/AMaintains
2 years ago
Allergan plcAGN
1HoldN/AN/ADowngrades
2 years ago
Iqvia Holdings IncIQV
2Buy$110.00N/AMaintains
2 years ago
Zoetis IncZTS
1Strong Buy$160.00N/AUpgrades
2 years ago
Teva Pharmaceutical Industries LtdTEVA
1Hold$13.00N/AMaintains
2 years ago
Charles River Laboratories International IncCRL
1Strong Buy$180.00N/AMaintains
2 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.